WO2009073782A3 - Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue - Google Patents

Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue Download PDF

Info

Publication number
WO2009073782A3
WO2009073782A3 PCT/US2008/085530 US2008085530W WO2009073782A3 WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3 US 2008085530 W US2008085530 W US 2008085530W WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3
Authority
WO
WIPO (PCT)
Prior art keywords
proliferative
pelvic
treatment
methods
proliferative agents
Prior art date
Application number
PCT/US2008/085530
Other languages
French (fr)
Other versions
WO2009073782A2 (en
Inventor
Thomas Q. Dinh
Original Assignee
Ams Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ams Research Corporation filed Critical Ams Research Corporation
Publication of WO2009073782A2 publication Critical patent/WO2009073782A2/en
Publication of WO2009073782A3 publication Critical patent/WO2009073782A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Abstract

A pelvic treatment device for localized delivery of one or more anti-proliferative agents to prevent further growth and development of female or male pelvic proliferative cells. With the benefit of localized delivery of the anti-proliferative agents, the anti-proliferative agents can be introduced to pelvic proliferative cells at dosage levels less than would be expected for conventional system delivery mechanisms so as to reduce or eliminated common side effects or toxic conditions. Generally, the one or more anti-proliferative drugs can be introduced in conjunction with or integral to a physical element that retains the anti-proliferative agents for localized release.
PCT/US2008/085530 2007-12-04 2008-12-04 Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue WO2009073782A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99221107P 2007-12-04 2007-12-04
US60/992,211 2007-12-04
US7563308P 2008-06-25 2008-06-25
US61/075,633 2008-06-25

Publications (2)

Publication Number Publication Date
WO2009073782A2 WO2009073782A2 (en) 2009-06-11
WO2009073782A3 true WO2009073782A3 (en) 2009-12-30

Family

ID=40718494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/085530 WO2009073782A2 (en) 2007-12-04 2008-12-04 Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue

Country Status (1)

Country Link
WO (1) WO2009073782A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8597262B2 (en) * 2009-07-09 2013-12-03 Ams Research Corporation Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6086909A (en) * 1997-06-11 2000-07-11 Umd, Inc. Device and method for treatment of dysmenorrhea
US6726923B2 (en) * 2001-01-16 2004-04-27 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20070026042A1 (en) * 2005-07-29 2007-02-01 Narayanan Pallasssana V System for treating aneurysmal disease
US20070049973A1 (en) * 2005-08-29 2007-03-01 Vascular Control Systems, Inc. Method and device for treating adenomyosis and endometriosis
US20070244071A1 (en) * 2006-03-07 2007-10-18 Mount Sinai Hospital Treatment of proliferative diseases

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6086909A (en) * 1997-06-11 2000-07-11 Umd, Inc. Device and method for treatment of dysmenorrhea
US6726923B2 (en) * 2001-01-16 2004-04-27 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20070026042A1 (en) * 2005-07-29 2007-02-01 Narayanan Pallasssana V System for treating aneurysmal disease
US20070049973A1 (en) * 2005-08-29 2007-03-01 Vascular Control Systems, Inc. Method and device for treating adenomyosis and endometriosis
US20070244071A1 (en) * 2006-03-07 2007-10-18 Mount Sinai Hospital Treatment of proliferative diseases

Also Published As

Publication number Publication date
WO2009073782A2 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
WO2012034685A3 (en) Implant delivery device intended to be attached to or interconnected with a catheter, implant delivery catheter and method
WO2006053308A3 (en) Improved energy delivery devices and methods
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
WO2006053309A3 (en) Improved energy delivery devices and methods
IL202614A0 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
TW200718689A (en) 2-Amino-quinazolin-5-ones
WO2007146426A3 (en) Nanoshells for drug delivery
EP2552356A4 (en) Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen
AP2011005780A0 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient.
WO2008151299A3 (en) Implantable medical devices for local and regional treatment
WO2011041221A3 (en) Water treatment cartridge
EP2019646A4 (en) Method, device, and system for delivery of therapeutic agents to the eye
WO2011041633A3 (en) Bottle for water treatment device
WO2009031606A1 (en) Therapeutic and prophylactic agents for arthritis
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
WO2009073307A3 (en) Implantable medical devices for local and regional treatment
WO2014036556A3 (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
WO2012011109A3 (en) Method for treating urinary incontinence
EP2789338A3 (en) Condensed pyridine derivate and use thereof
BR112012013011A2 (en) odt; odt composition; method for preparing a multiparticulate odt tablet, method for treating or preventing postoperative nausea and vomiting or post-discharge nausea and vomiting for up to 24 hours after dosing, method for treating pu preventing nausea for up to 24 hours after dosing and Method for treating or preventing nausea and vomiting associated with radiotherapy in patients receiving either full body irradiation, single high dose to the abdomen, or daily fractions to the abdomen for up to 24 hours after dosing.
MX2012007234A (en) Calcipotriol monohydrate nanocrystals.
WO2009073782A3 (en) Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
WO2009111681A3 (en) Gallium compounds and methods of use to treat inflammatory bowel disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08856678

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08856678

Country of ref document: EP

Kind code of ref document: A2